Evidence map›Paper›PMID 42695409›Full record

ArticleMolecular medicine reports2026

[Corrigendum] CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma.

Qianle Yu, Kai Gao

Abstract readPublished Erratum
In one paragraph

Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Qianle YuDepartment of General Surgery and Institute of Digestive Surgery, The Affiliated Changsha Hospital of Hunan Normal University, Changsha, Hunan 410006, P.R. China.
Kai GaoDepartment of Gastrointestinal Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above article, the authors have contacted the Editorial Office to explain that certain of the western blots featured in Figs. 3A and B, and 6A and B, on p. 2248 and 2250 respectively were chosen incorrectly. Specifically, the data chosen for the CLEC4M blots in Fig. 3A and B, and the p‑JAK1 blots in Fig. 6A and the STAT3 blots in Fig. 6B, were presented incorrectly in these figures. However, the authors retained their original data, and have submitted corrected versions of Figs. 3 and 6, now showing the correct data for the CLEC4M blots in Fig. 3A and B, and the p‑JAK1 blots in Fig. 6A and the STAT3 blots in Fig. 6B. These figures are featured on the next page. Note that the errors made in compiling these figures did not affect the results or the main conclusions reported in the study. All the authors approve of the publication of this corrigendum, and are grateful to the Editor of

Indexed as

apoptosisC‑ type lectin domain family 4 member Mhepatocellular carcinomaprognosisproliferation

Identifiers

PMID42695409
PMCPMC13573278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.